Skip Navigation
Skip to contents

ICoLA 2019

Today : 2019.10.22
D- -47
The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea
Key Speakers
  • Stefano Del Prato, M.D. (University of Pisa, Italy) The Benefits of GLP 1-RA and SGLT2 Inhibitor for the CV Outcomes: What is Similar or Different?
    Ira J. Goldberg, M.D. (New York University, USA) My Sweet Heart Was Broken: Fat Metabolism and Diabetes in the Heart
  • Kenneth Walsh, Ph.D. (University of Virginia, USA) Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease
    Gregory G. Schwartz, M.D., Ph.D. (University of Colorado, USA) Metformin: Is it a Cardiovascular Drug?
  • Laurent Yvan-Charvet, Ph.D. (Institut national de la sante et de la recherche medicale, France) Metabolic Reprogramming of Macrophage in Atherosclerosis: Is it All about Cholesterol?
    Sripal Bangalore, M.D. (New York University, USA) Cardiovascular Risk Factors - It's Time to Focus on Variability
Deadlines
  • Late-breaking Abstract Submission June 19 (Wed.), 2019 closed
  • Notification of AcceptanceJuly 05 (Fri.), 2019
  • Pre-registrationAugust 16 (Fri.), 2019 closed
News & Notice

View More

Photo Gallery

IVBM 2020 Website

Sep. 9~12, 2020
Conrad Hotal, Seoul, Korea

ICoLA 2019

Close

Sponsored by
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Joong-Yeol Park

Secretariat of ICoLA 2019 │ People & Value, Inc.

#1001 Botanic Park Tower, Magok-joongang-ro 161-17, Gangseo-gu, Seoul, Korea

Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.